472 related articles for article (PubMed ID: 30383881)
1. Use of Buprenorphine to Treat Opioid Use Disorder.
Bartholow LAM; Pope J
J Psychosoc Nurs Ment Health Serv; 2018 Nov; 56(11):9-12. PubMed ID: 30383881
[TBL] [Abstract][Full Text] [Related]
2. The role of NPs in medication-assisted treatment for opioid use disorder.
Cotton BP; Ferszt GG
Nurse Pract; 2018 May; 43(5):8. PubMed ID: 29668514
[No Abstract] [Full Text] [Related]
3. Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential.
Sigmon SC; Bigelow GE
Addiction; 2017 Mar; 112(3):386-387. PubMed ID: 27561982
[No Abstract] [Full Text] [Related]
4. Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic.
Peckham AM; Ball J; Colvard MD; Dadiomov D; Hill LG; Nichols SD; Tallian K; Ventricelli DJ; Tran TH
Am J Health Syst Pharm; 2021 Mar; 78(7):613-618. PubMed ID: 33411894
[TBL] [Abstract][Full Text] [Related]
5. Recovery Beyond Buprenorphine: Nurse-Led Group Therapy.
Fogger SA; Lehmann K
J Addict Nurs; 2017; 28(3):152-156. PubMed ID: 28863059
[TBL] [Abstract][Full Text] [Related]
6. Using buprenorphine to treat patients with opioid use disorder.
Radi JK; Fogarty KJ; Lagerwey MD
JAAPA; 2019 Oct; 32(10):30-35. PubMed ID: 31513035
[TBL] [Abstract][Full Text] [Related]
7. Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting.
Cisewski DH; Santos C; Koyfman A; Long B
Am J Emerg Med; 2019 Jan; 37(1):143-150. PubMed ID: 30355476
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
Jones CM; McCance-Katz EF
Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
[TBL] [Abstract][Full Text] [Related]
9. The Number Needed to Prescribe - What Would It Take to Expand Access to Buprenorphine?
Poorman E
N Engl J Med; 2021 May; 384(19):1783-1784. PubMed ID: 33983689
[No Abstract] [Full Text] [Related]
10. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine Supply, Access, and Quality: Where We Have Come and the Path Forward.
Breen CT; Fiellin DA
J Law Med Ethics; 2018 Jun; 46(2):272-278. PubMed ID: 30147002
[TBL] [Abstract][Full Text] [Related]
12. CE: Acute Pain Management for People with Opioid Use Disorder.
Broglio K; Matzo M
Am J Nurs; 2018 Oct; 118(10):30-38. PubMed ID: 30211703
[TBL] [Abstract][Full Text] [Related]
13. The case for a medication first approach to the treatment of opioid use disorder.
Winograd RP; Presnall N; Stringfellow E; Wood C; Horn P; Duello A; Green L; Rudder T
Am J Drug Alcohol Abuse; 2019; 45(4):333-340. PubMed ID: 31084515
[No Abstract] [Full Text] [Related]
14. Emergency Department Initiation of Buprenorphine for Opioid Use Disorder: Current Status, and Future Potential.
Fox L; Nelson LS
CNS Drugs; 2019 Dec; 33(12):1147-1154. PubMed ID: 31552608
[TBL] [Abstract][Full Text] [Related]
15. Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.
Burns RM; Pacula RL; Bauhoff S; Gordon AJ; Hendrikson H; Leslie DL; Stein BD
Subst Abus; 2016; 37(1):63-9. PubMed ID: 26566761
[TBL] [Abstract][Full Text] [Related]
16. Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence.
Godersky ME; Saxon AJ; Merrill JO; Samet JH; Simoni JM; Tsui JI
Addict Sci Clin Pract; 2019 Mar; 14(1):11. PubMed ID: 30867068
[TBL] [Abstract][Full Text] [Related]
17. Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007-2017.
McBain RK; Dick A; Sorbero M; Stein BD
Ann Intern Med; 2020 Apr; 172(7):504-506. PubMed ID: 31905379
[No Abstract] [Full Text] [Related]
18. Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine.
Chou R; Ballantyne J; Lembke A
Ann Intern Med; 2019 Sep; 171(6):427-429. PubMed ID: 31450240
[No Abstract] [Full Text] [Related]
19. Stigma associated with medication treatment for young adults with opioid use disorder: a case series.
Hadland SE; Park TW; Bagley SM
Addict Sci Clin Pract; 2018 May; 13(1):15. PubMed ID: 29730987
[TBL] [Abstract][Full Text] [Related]
20. Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder.
Davis CS; Carr DH; Glenn MJ; Samuels EA
Ann Emerg Med; 2021 Jul; 78(1):102-108. PubMed ID: 33781607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
